Design, Synthesis, and Evaluation of Novel Quinazolin-4(3H)-One Derivatives: Anti-Leishmanial Activity, Selectivity, and Molecular Docking Insights
 
Yazarlar (6)
Dr. Öğr. Üyesi Baycan MOR Kafkas Üniversitesi, Türkiye
Doç. Dr. Feyzi Sinan TOKALI Kafkas Üniversitesi, Türkiye
Dr. Öğr. Üyesi Barış Yıldız Kafkas Üniversitesi, Türkiye
Doç. Dr. Halil Şenol Bezm-İ Âlem Vakıf Üniversitesi, Türkiye
Arş. Gör. Şeyma AKSU Kafkas Üniversitesi, Türkiye
Doç. Dr. Neriman MOR Kafkas Üniversitesi, Türkiye
Makale Türü Açık Erişim Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Journal of Biochemical and Molecular Toxicology (Q2)
Dergi ISSN 1095-6670 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce Basım Tarihi 05-2025
Cilt / Sayı / Sayfa 39 / 6 / – DOI 10.1002/jbt.70309
Makale Linki https://onlinelibrary.wiley.com/doi/10.1002/jbt.70309
UAK Araştırma Alanları
Organik Kimya
Özet
In this study, 16 novel quinazolin‐4(3H)‐one derivatives were synthesized and evaluated for their antileishmanial activity against Leishmania major and Leishmania donovani. Among them, compounds 2 (4‐hydroxy substituted) and 9 (4‐morpholino substituted) exhibited the highest efficacy, with compound 2 showing IC50 values of 23.94 μM for L. major and 90.80 μM for L. donovani, while compound 9 demonstrated IC50 values of 23.05 μM for L. major and 56.30 μM for L. donovani. Miltefosine, the reference drug, showed IC50 values of 32.89 μM for L. major, 4.78 μM for L. donovani, and 7.53 μM for HUVEC cells. Compound 2 showed superior selectivity (SI = 15.2 for L. major and 4.0 for L. donovani) compared to miltefosine (SI = 4.4 for L. major and 0.6 for L. donovani). Molecular docking studies identified phosphodiesterase B1 (PDEB1) as a key target, with compound 2 showing the strongest …
Anahtar Kelimeler
ADME | cell viability | Leishmania spp | leishmaniasis | molecular docking | NMR | quinazolin-4(3H)-one | synthesis
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Web of Science 2
Scopus 2
Google Scholar 3
Design, Synthesis, and Evaluation of Novel Quinazolin-4(3H)-One Derivatives: Anti-Leishmanial Activity, Selectivity, and Molecular Docking Insights

Paylaş